BioSpace News Archive

Zhongchao Inc. Announces Its Patient Management System Improves Its Liver Cancer Patients’ Duration of Therapy by 40%, Promoting Successful Treatment

Zhongchao Inc. today announced its self-developed patient management system improves Duration of Therapy (“DOT”) by 40.4% for liver cancer patients, which contributes to the maximum efficiency of drugs, successful treatment and longer patient survival terms.

October 29, 2021
·
4 min read
Business

Caris Precision Oncology Alliance Partners with the National Cancer Institute, Part of the National Institutes of Health, to Expand Collaborative Clinical Research Efforts

Caris Life Sciences®, a molecular science company developing and delivering technologies to revolutionize healthcare, announced that the Caris Precision Oncology Alliance™ and NCI’s Center for Cancer Research will collaborate on precision medicine research initiatives.

October 29, 2021
·
6 min read
Business

ImmunoGen Reports Recent Progress and Third Quarter 2021 Financial Results

We look forward to announcing top-line data from our pivotal SORAYA trial this quarter, including data on the primary endpoint of overall response rate and key secondary endpoint of duration of response.

October 29, 2021
·
10 min read
Business

IRADIMED CORPORATION Announces Third Quarter 2021 Financial Results

IRADIMED CORPORATION today announced financial results for the three and nine months ended September 30, 2021.

October 29, 2021
·
15 min read
Business

Cyclacel Pharmaceuticals to Release Third Quarter 2021 Financial Results and Provide Business Update

Cyclacel Pharmaceuticals, Inc. will announce third quarter financial results and provide a business update on Wednesday, November 10, 2021.

October 29, 2021
·
3 min read
FDA

Magnus Medical Launches With Breakthrough Device Designation for Rapid, Individualized Treatment of Major Depression and $25M in Series A Financing

Magnus Medical, Inc. today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its individualized, rapid-acting, non-invasive neurostimulation technology designed to treat major depressive disorder (MDD)

October 29, 2021
·
6 min read
Genetown

Despite Recent FDA Hold, US Cancer Specialists Are Enthusiastic About CAR T-Cell Therapies, Says InCrowd Instant Insights Data

Despite the FDA’s recent hold on select chimeric antigen receptor, new data show US oncologists, hematologists, and hematology-oncologists remain highly enthusiastic about the potential for CAR T-cell therapies for their patients.

October 29, 2021
·
3 min read
Biotech Beach

Biomerica Launches New Website for Its Aware® Breast Exam Device

Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that in conjunction with Breast Cancer Awareness month, which takes place each October, it has launched its new website for the Aware® at-home breast self-exam pad. Breast cancer is the most commonly-diagnosed cancer in women.

October 29, 2021
·
4 min read
Pharm Country

The UroLift® System Receives Bronze Award for Best New Branded Television Campaign and Honorable Mention in the Best Branded Website Category from DTC Perspectives

Teleflex Incorporated (NYSE: TFX) announced today that the UroLift® System was honored by DTC Perspectives with a Bronze Award in the “Best New Branded Television Campaign” category and an Honorable Mention in the “Best Branded Website” category.

October 29, 2021
·
5 min read
BioForest

Athira Pharma to Host Educational Webinar on the Clinical Applications of ERP P300

Neurologist Dr. John Michael Olichney to discuss utility of P300 to assess cognitive function Webinar to be held Friday, Nov. 5, at 9 a.m. PT / 12 p.m. ET

October 29, 2021
·
3 min read